MF6.STU MagForce AG

Healthcare Health Care Equipment & Supplies Stuttgart Exchange
0.0030 EUR
Close of Oct 22, 2026
0.0010 0.0140
Market cap
EUR 89.8K
P/E
-
P/B
0.00x
ROE
-39.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2021.

Is MF6.STU undervalued?

Graham number

The Graham number of MagForce AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MagForce AG fundamental analysis

No fundamental analysis for MagForce AG yet.

MagForce AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MagForce AG

MagForce AG develops advanced nanomedicine for cancer therapies. It offers NanoTherm therapy system, a combination of medical devices for the treatment of solid brain tumors; NanoPlan, a software that stimulates the temperature distribution in the treatment area; NanoTherm, a magnetic ferrofluid; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.

Full company profile